Skin sentry cells promote distinct immune responses

July 21, 2011 in Medical research

A new study reveals that just as different soldiers in the field have different jobs, subsets of a type of immune cell that polices the barriers of the body can promote unique and opposite immune responses against the same type of infection. The research, published online on July 21st by Cell Press in the journal Immunity, enhances our understanding of the early stages of the immune response and may have important implications for vaccinations and treatment of autoimmune diseases.

Dendritic cells serve as sentries of the immune system and are stationed at the body's "outposts," like the skin, where they are likely to encounter invading pathogens. When dendritic cells encounter pathogen-associated antigens (molecules that trigger an immune response), they process the antigen and present it to other responding in an effort to inititate a cellular cascade resulting in clearance of the pathogen. This is a critical part of the immune response because many responding immune cells cannot "see" antigen and initiate the proper unless the antigen is properly presented by a dendritic cell.

"There are at least three different types of dendritic cells in the skin," explains senior study author, Dr. Daniel Kaplan from the University of Minnesota. "Despite studies examining these cells, the basic question of whether skin resident dendritic cells have unique or redundant functions remains unresolved." Dr. Kaplan and colleagues developed a model of that is limited to the superficial layer of the skin and studied antigen-specific immune responses in mice lacking specific subsets of skin dendritic cells.

The researchers discovered that direct presentation of antigen by one type of dendritic cell, Langerhans cells, was necessary and sufficient for the generation of antigen-specific T helper-17 (Th17) cells but not the generation of cytotoxic lymphocytes (CTL). T play a key role in orchestrating the , whereas CTLs can directly destroy infected cells. While Th17 cells play productive roles in indirectly eliminating pathogens when their response is dysregulated, they have been implicated in autoimmune disease, Meanwhile, another subset of dendritic cells was required for the generation of antigen-specific CTLs and inhibited the ability of other dendritic cells to promote Th17 cell responses.

"Our work demonstrates that in the skin promote distinct and opposing antigen-specific responses," concludes Dr. Kaplan. "This has important implications for vaccination strategies that selectively target dendritic cell populations. In addition, the requirement for Langerhans cells in the development of Th17 cells suggests these cells may participate in the early pathogenesis of Th17 cell-mediated skin diseases such as psoriasis."

Provided by Cell Press search and more info website

5 /5 (2 votes)  

Rank 5 /5 (2 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

H. pylori, smoking trends, and gastric cancer in US men

Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...

Medical research created 9 hours ago | popularity not rated yet | comments 0

Common food supplement fights degenerative brain disorders

Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...

Medical research created 13 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Finding a family for a pair of orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...

Medical research created 14 hours ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

Medical research created 14 hours ago | popularity 4.6 / 5 (7) | comments 0 | with audio podcast

Do men's and women's hearts burn fuel differently?

Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...

Medical research created 17 hours ago | popularity not rated yet | comments 0


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.